Dr. Larry Kwak, MD, PhD, MD Anderson Cancer Center Interview Date: September 26, 2014
Dr. Larry Kwak describes his remarkable work to create the very ultimate in personalized myeloma immunotherapy - a vaccine tailored to each myeloma patient's particular genetic signature. He describes how it works: some of the tumor cells are pulled out, purified and then packaged with a protein or immune system stimulant and given back to the patient, making it the first and only truly individualized treatment option. He notes that vaccines are best used when patients have a very low tumor burden and describes how this vaccine is being used in a clinical trial along with T cells and autologous stem cell transplant at MD Anderson. Learn more about this very unique and exciting advance in myeloma care. The live mPatient Myeloma Radio podcast with Dr. Larry Kwak, MD, PhD
Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
+1 800 709 1113